Toll Free: 1-888-928-9744

Global Hemophilia A Market 2015-2019

Published: Sep 30, 2015 | Pages: 68 | Publisher: Technavio | Industry: Pharmaceutical | Report Format: Electronic (PDF)

About hemophilia A
Hemophilia is a rare bleeding disorder caused by deficiency of clotting factors such as VIII and IX. It is an X-linked recessive disorder, which is more prevalent in males than in females. It is estimated that it affects around 400,000 people per year. The two major types of hemophilia are A and B. Hemophilia A, also called as classical hemophilia or factor VIII deficiency hemophilia, is caused by deficiency of clotting factor VIII. It is transmitted genetically from parent to child during birth. Recombinant clotting factors or plasma-derived clotting factors are being developed for the treatment of this disorder.

Technavio's analysts forecast the global hemophilia A drugs market to grow at a CAGR of 6.25% over the period 2014-2019. 
    
Covered in this report
The report covers the current scenario and the growth prospects of the global hemophilia A drugs market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment and prevention of hemophilia A. In this report, the market is also segmented based on the type of therapy.

Technavio's report, Global Hemophilia A Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC, Europe, and Americas; it also covers the landscape of the global hemophilia A drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key region
 Americas
 APAC
 Europe 

Key vendors
 Baxter International 
 Bayer's 
 CSL Behring 
 Novo Nordisk 
 Pfizer

Other prominent vendros
 Alnylam Pharmaceuticals 
 Amarna Therapeutics 
 Asklepios
 Biogen Idec
 Catalyst Biosciences 
 Dimension Therapeutics 
 Dong-A Socio 
 Emergent BioSolutions 
 Grifols 
 Inspiration Biopharmaceuticals 
 Kedrion Biopharma 
 Octapharma 
 OPKO Health 
 rEVO Biologics 
 Sangamo BioSciences 
 Spark Therapeutics
 UniQure 

Market driver
 Development of drugs with prolonged action 
 For a full, detailed list, view our report

Market challenge
 High cost of therapy 
 For a full, detailed list, view our report

Market trend
 Advances in technology 
 For a full, detailed list, view our report

Key questions answered in this report
 What will the market size be in 2019 and what will the growth rate be?
 What are the key market trends?
 What is driving this market?
 What are the challenges to market growth?
 Who are the key vendors in this market space?
 What are the market opportunities and threats faced by the key vendors?
 What are the strengths and weaknesses of the key vendors?
 Table of Contents
PART 01: Executive summary Highlights PART 02: Scope of the report Market overview Top-vendor offerings PART 03: Market research methodology Research methodology Economic indicators PART 04: Introduction Key market highlights PART 05: Disease overview Understanding the disease Risk factors Signs and symptoms Diagnosis Treatment Epidemiology PART 06: Pipeline portfolio Key information on pipeline candidates PART 07: Market landscape Market overview Market size and forecast Five forces analysis PART 08: Segmentation by type of therapy Plasma-derived therapies Recombinant therapies PART 09: Segmentation by disease management On-demand therapy Prophylaxis Inhibitors PART 10: Geographical segmentation PART 11: Market drivers PART 12: Impact of drivers PART 13: Market challenges PART 14: Impact of drivers and challenges PART 15: Market trends PART 16: Vendor landscape Competitive scenario Market share analysis 2014 Other prominent vendors PART 17: Key vendor analysis Baxter Bayer HealthCare CSL Behring Pfizer PART 18: Appendix List of abbreviations PART 19: Explore Technavio ? List of Exhibits Exhibit 01: Product offerings Exhibit 02: Number of prevalence cases of hemophilia A in five countries 2011 Exhibit 03: Key late-stage drugs under development for hemophilia A Exhibit 04: Global hemophilia A drugs market 2014-2019 ($ billions) Exhibit 05: Five forces analysis Exhibit 06: Global hemophilia A drugs market by type of therapy Exhibit 07: Segmentation by type of therapy for hemophilia A Exhibit 08: Global hemophilia A drugs market by disease management Exhibit 09: Types of prophylaxis Exhibit 10: Segmentation by disease management of hemophilia A Exhibit 11: Segmentation of global hemophilia A drugs market by geography in 2014 Exhibit 12: Impact of drivers Exhibit 13: Impact of drivers and challenges Exhibit 14: Baxter: Global YoY growth and revenue of hemophilia products 2012-2014 ($ millions) Exhibit 15: Baxter: Key takeaways Exhibit 16: Novo Nordisk: Global YoY growth and revenue of hemophilia products 2012-2014 ($ millions) Exhibit 17: Novo Nordisk: Key takeaways Exhibit 18: Bayer: Global YoY growth and revenue of Kogenate FS 2012-2014 ($ millions) Exhibit 19: Bayer's: Key takeaways Exhibit 20: Pfizer: Global YoY growth and revenue of Xyntha/ReFactoAF 2012-2014 ($ millions) Exhibit 21: Pfizer: Key takeaways Exhibit 22: CSL Behring: Global YoY growth and revenue of hemophilia products 2013-2014 ($ millions) Exhibit 23: CSL Behring: Key takeaways Exhibit 24: CSL Behring: Product segmentation by revenue 2014 Exhibit 25: CSL Behring: Geographical segmentation by revenue 2014 Exhibit 26: Novo Nordisk: Business segmentation by revenue 2014 Exhibit 27: Novo Nordisk: Business segmentation by revenue 2013 and 2014 Exhibit 28: Novo Nordisk: Geographical segmentation by revenue 2014 Exhibit 29: Novo Nordisk: R&D expenditure 2014

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global coated fabrics market size forecast is estimated at USD 22.57 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing production of seat covers & airbags for automobile applications is likely to favor market growth.

Read More...

Global sorbitol market size is anticipated to be reach USD 3.99 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing consumer perception towards product benefits derived from natural ingredients is expected to drive the dem

Read More...

Global outsourced customer care services market is projected to reach USD 84.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Swelling need for interaction through non-voice channels is estimated to boost global demand over t

Read More...

Global lignin market size is expected to exceed USD 6 billion by 2022, growing at 4.9% from 2015 to 2022. Rising demand for animal feed and potential as a feedstock substitute to crude oil are expected to drive lignin market demand over the forecast

Read More...

Global activated carbon market size is likely to be valued at USD 5.3 billion by 2020; as per a new research report by Radiant Insights, Inc. Increase in commercial & residential waste water treatment demand owing to escalation in water prices is ant

Read More...
Choose License Type
Single User - US $2500
Multi User - US $4000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify